SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

~~FORM~~Form 8-K

Current Report Pursuant to Section 13 or 15(d) of the Securities Act of 1934

Date of Report: ~~June~~August 221, 2011

~~ANGEL~~BIOGERON, ~~ACQUISITION CORP~~INC.

(Exact name of registrant as specified in its charter)

Nevada	8806-~~0470235~~1588136
(State of incorporation)	(IRS Employer ID Number)
1802 N. Carson Street, Suite 212-3018, Carson City, Nevada	89701
(Address of principal executive offices)	(Zip Code)

(775) 887-0670

(Issuer's telephone number)

~~N/A(Former~~ANGEL ~~name, if changed since last report)~~ACQUISITION CORP.

(Former name, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ]

Written communications pursuant to Rule 425 under the Securities Act

[ ]

Soliciting material pursuant to Rule 14a-12 under the Exchange Act

[ ]

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

[ ]

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

SECTION 53 – ~~CORPORATE~~SECURITIES ~~GOVERNANCE~~ AND ~~MANAGEMENT~~TRADING MARKETS

ITEM 53.0203 ~~DEPARTURE~~Material OFModification ~~DIRECTORS~~of ORRights ~~PRINCIPAL~~of ~~OFFICERS;~~Security ~~ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS.~~Holders

On August 2, 2011, the Company filed a Certificate of Change with the Nevada Secretary of State in order to effectuate a one for fifteen thousand nine hundred (1:15,900) reverse stock split (the “Reverse Split”) and a contemporaneous one for fifteen thousand nine hundred (1:15,900) reduction in the number of the Company’s authorized shares of common stock, par value $0.00001 (the "Common Stock"), in accordance with the procedure authorized by Nevada Revised Statutes (NRS) 78.207. The board of directors determined that it would be in the Company's best interest to effect the Reverse Split and approved this corporate action by unanimous written consent. The Reverse Split does not require shareholder approval.

OnThe ~~June~~Certificate ~~22, 2011, the Registrant accepted the resignations~~ of ~~Steven~~Change ~~Bonenberger~~is attached as ~~Chief~~Exhibit ~~Executive~~3.13 ~~Officer,~~to ~~President,~~this ~~Secretary~~Current ~~and~~Report ~~Chief Financial Officer of the Registrant. Effective~~ on ~~the~~Form ~~same~~8-K ~~date the Registrant appointed Michael Edwards as Chief Executive Officer, President, Secretary, Chief Financial Officer~~ and ~~member~~incorporated ofherein ~~the~~by ~~Board of Directors~~reference.

~~(b)~~SECTION 5 – CORPORATE GOVERNANCE AND MANAGEMENT

OnItem ~~June~~5.03 ~~23,~~Amendments ~~2011,~~to ~~the~~Articles ~~Registrant accepted the resignation~~ of ~~Steven~~Incorporation ~~Bonenberger~~or asBylaws; aChange ~~member~~in ofFiscal ~~the Board of Directors of the Registrant~~Year.

~~Mr.~~On ~~Bonenberger's~~August ~~resignations~~1, ~~did~~2011, ~~not~~the ~~arise~~Company ~~from~~filed ~~any~~Articles ~~disagreement~~of onMerger ~~any~~with ~~matter~~the ~~relating~~Secretary of State of Nevada in order to effectuate a merger whereby the Company’s ~~operations,~~(as ~~policies~~Angel orAcquisition ~~practices~~Corp.) merged with its wholly-owned subsidiary, ~~nor~~BioGeron, ~~regarding~~Inc., as a parent/ subsidiary merger with the ~~general~~Company ~~direction~~as the surviving corporation. This merger, which became effective as of August 1, 2011, was completed pursuant to NRS 92A.180. Shareholder approval to this merger was not required under NRS 92A.180. In process of the merger, the Company's name has been changed to "BioGeron, Inc." and the Company's Articles of Incorporation have been amended to reflect this name change.

~~Biographical~~The ~~information~~Articles ~~for~~of ~~Michael~~Merger ~~Edwards~~are attached as Exhibit 3.14 to this Current Report on Form 8-K and incorporated herein by reference.

~~Mr.~~In ~~Edwards~~connection ~~has~~with ~~extensive~~the ~~experience~~Reverse inSplit ~~nutrition, marketing~~ and ~~product~~name ~~distribution.~~change, ~~His~~we ~~current~~have ~~focus is on~~ the ~~study~~following ofnew ~~Anti-Aging~~CUSIP ~~and~~number: ~~Life-Extension~~09072F ~~nutraceutical science~~100. ~~His~~We ~~mission~~have issubmitted ~~to bring a product to~~ the ~~public~~required ~~that~~information ~~will improve their ability~~ to ~~extend~~FINRA ~~life~~ and ~~experience~~expect ~~a healthy life. He owned and managed a retail health-food company in Southern California before moving~~ to ~~Los~~receive ~~Angeles~~an ineffective ~~1989~~date ~~where~~and henew ~~created~~trading ~~Premier~~symbol ~~Attractions,~~soon afor ~~marketing~~the ~~firm~~corporate ~~that created and distributed products worldwide~~actions.

~~Mr.~~SECTION ~~Edwards~~9 is– aFINANCIAL ~~published~~STATEMENTS ~~author~~AND and inventor with a diverse educational, financial, business and a research background. This background has provided a strong work ethic and created success-driven protocols which have sustained a continued interest in the bio-nutraceutical and health-science industry.EXHBITIS

InItem ~~addition to his health science background, Mr~~9.01 ~~Edwards brings a wealth of experience from writing, directing, production and distribution in the film, television and video industries, as well as substantial banking and publishing experience.~~Exhibits

SIGNATURES


Exhibit Number	Description
3.13	Certificate of Change
3.14	Articles of Merger

~~Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.~~ 2

2SIGNATURES

~~ANGEL~~Pursuant ~~ACQUISITION~~to ~~CORP~~the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

June 24, 2011	/s/ Michael Edwards
Date	Michael Edwards, Chief Executive Officer

BIOGERON, INC.

3Date: August 5, 2011 /s/ Michael Edwards Michael Edwards, Chief Executive Officer

Filing Compare · BIOGERON, INC.